Why these 4 shares smashed the market today

Could there be more where that came from for Greencross Limited (ASX:GXL), Monadelphous Group Limited (ASX:MND), Mesoblast Limited (ASX:MSB), and Fortescue Metals Group Limited (ASX:FMG)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today was another buoyant day for the S&P/ASX 200 (INDEXASX: ^AXJO) (ASX: XJO) with our index rising 0.9% to 4,887 points, again as a result of a strong lead from overseas markets.

These four shares considerably outperformed the market today, and here's why:

Greencross Limited (ASX: GXL) rose 5% to $6.89 after the pet retailer and vet operator released its interim results to the market this morning. A strong set of results combined with a third takeover bid recently at an increased price of $6.75 per share seemed sure to push share prices higher, and that's exactly what happened. Investors should be cautious that there is no certainty a higher bid will materialise after Greencross management knocked back the latest offer. In the meantime, shareholders can enjoy rising dividends and earnings from the petcare provider.

Greencross shares are down 18% in the past 12 months.

Monadelphous Group Limited (ASX: MND) gained 3% to $5.83 after its interim results were released to the market this morning. The share price reaction seems a little surprising given that Monadelphous recorded a 30% decline in revenues and a 38% decline in profits for the past six months. Possibly results weren't as bad as investors were expecting, or the huge interim dividend on offer attracted the bargain hunters.

Monadelphous shares are down 39% in the past 12 months.

Mesoblast limited (ASX: MSB) shares skyrocketed 17% to $1.36 after the company announced positive progress with its Phase 2 rheumatoid arthritis trials. A fair number of patients experienced improvements in the 12-week program, although the trial's primary focus was safety, and not efficacy. Mesoblast shares have been in the news recently after Credit Suisse in the US set a price target significantly higher than today's prices, and declared that the stock has blockbuster potential. However, Mesoblast remains unprofitable and is burning a lot of cash in its quest to develop saleable treatments.

Mesoblast shares are down 66% in the past 12 months.

Fortescue Metals Group Limited (ASX: FMG) jumped 11% to $1.90 today after iron ore prices rose above US$46 per tonne overnight. However, investors should be cautious that current demand is not enough to sustain higher prices, and low smelter utilisation rates in China should be an item of great concern for shareholders of iron ore miners. Fortescue has been a regular feature in the stocks moving up/down articles recently because of its exposure to the volatile iron ore price, and shareholders should expect continued volatility going forwards.

Fortescue shares are down 29% in the past 12 months.

Motley Fool contributor Sean O'Neill owns shares of Greencross Limited. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »